SEC Form 4 · accession 0001437749-26-022969
BioCardia, Inc. · BCDA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Peter Altman
Officer — President and CEO · Director
Period of report
Jul 2, 2026
Accepted (ET)
Jul 7, 2026 · 10:03 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0000925741
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jul 2, 2026 | F | 54,606 | $1.24 | D | 356,585 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2 | $1.20 | Jul 6, 2026 | A | 57,688 | A | — | Jul 6, 2036 | Common stock | 57,688 | 147,903 | D |
Explanation of responses
- F1The reported securities represent the shares that have been withheld by the Issuer to satisfy its income tax, withholding and remittance obligations in connection with the net settlement on July 2, 2026, of the RSUs vested on June 29, 2026 and does not represent a sale by the Reporting Person.
- F2The option vests and becomes exercisable as to 1/48th of the shares on August 6, 2026, and each month thereafter, subject to the Reporting Person continuing as a service provider through such date.